Results 171 to 180 of about 6,337 (212)
Some of the next articles are maybe not open access.

[SIADH and vaptans].

Annales d'endocrinologie, 2012
The vaptans are non-peptide arginine-vasopressin-receptor antagonists, that are orally and intravenously active. A few vaptans have undergone sufficient clinical development to be on the market. In the EU only tolvaptan is accepted to treat hyponatremia related to SIADH. The place of this new treatment is compared with water restriction, demeclocyclin,
openaire   +1 more source

Wallenberg Syndrome with SIADH

European Neurology, 2004
Nobuatsu, Nomoto   +4 more
openaire   +2 more sources

Hyponatremia: SIADH

2021
Raghav Wusirika, David H. Ellison
openaire   +1 more source

Carbamazepine and SIADH

American Journal of Psychiatry, 1990
openaire   +2 more sources

Medication-Induced SIADH: Distribution and Characterization According to Medication Class

British Journal of Clinical Pharmacology, 2017
Talia Diker-Cohen   +2 more
exaly  

Home - About - Disclaimer - Privacy